We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Silica-Based Nanoparticles Selectively Kill Lung Cancer Cells

By LabMedica International staff writers
Posted on 16 Mar 2015
Print article
Image: TEM (transmission electron micrograph) of a mesoporous silica nanoparticle (Photo courtesy of Wikimedia Commons).
Image: TEM (transmission electron micrograph) of a mesoporous silica nanoparticle (Photo courtesy of Wikimedia Commons).
A novel approach to the selective delivery of toxic chemotherapeutic agents is based on nanoparticles that sequester the drug until it is liberated by the action of specific proteases that are present in a high concentration inside lung cancer cells.

Investigators at the German Research Center for Environmental Health (Munich, Germany) constructed the nanoparticles—basically extremely small open-ended boxes—from mesoporous silica (containing pores with diameters between two and 50 nanometers) tightly capped at each end by avidin molecules linked by proteins sensitive to the action of the protease MMP9 (matrix metalloproteinase 9). The nanoparticles were loaded with the cancer drug cisplatin, which was safely sequestered as long as the avidin-protein caps remained intact.

The justification for use of these nanoparticles was the fact that the protease MMP9 was overexpressed in tumors. It was known to enhance the metastatic potency of malignant cells and had been associated with poor prognosis of lung cancer.

The investigators studied the impact of cisplatin-containing nanoparticles on mouse tumors in vivo and on mouse and human lung tumors being grown in novel ex vivo three-dimensional lung tissue cultures.

They reported in the February 22, 2015, online edition of the journal ACS Nano that the MMP9-mediated release of cisplatin induced apoptotic cell death only in lung tumor regions of Kras mutant mice without causing toxicity in tumor-free areas or in healthy mice. The MMP9-responsive nanoparticles also allowed for effective combinatorial drug delivery of cisplatin and the proteasome inhibitor bortezomib, which had a synergistic effect on the therapeutic efficiency. The concentration of MMP9 in healthy lung tissue was too low to destroy the nanoparticles' protective layer and the drugs remained sequestered inside the nanocarriers.

"Using these nanocarriers we can very selectively release a drug such as a chemotherapeutic agent specifically at the lung tumor," said senior author Dr. Silke Meiners, a group leader at the German Research Center for Environmental Health. "We observed that the drug's effectiveness in the tumor tissue was 10 to 25 times greater compared to when the drugs were used on their own. At the same time, this approach also makes it possible to decrease the total dose of medicines and consequently to reduce undesirable effects."

Related Links:

German Research Center for Environmental Health


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Automated Blood Typing System
IH-500 NEXT
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Newborn Screening Test
NeoMass AAAC 3.0

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.